Understanding the patient perspective is crucial for creating impactful brand strategies. Knowing what patients need and want from pharmaceutical products and from their HCPs about those products forms the foundation of commercial strategy. Yet, when it comes to pediatric patients, many pharmaceutical brand and research teams hesitate to delve deeper into this complex and sensitive demographic, instead relying on physicians and caregivers to relay youths’ needs and wants. However, listening directly to the pediatric voice offers valuable insights critical to shaping your brand’s approach by ensuring that your brand meets the needs of this important population as their own needs develop and change across childhood and adolescence and into young adulthood.
Join us in this compelling episode of our podcast, where we break down the barriers and uncover the immense potential that pediatric-focused research holds. Our expert panel discusses innovative strategies and share their experience, making this a must-listen for all pharma commercial professionals looking to elevate their insights, deliver a commercial edge for their brands and ultimately contribute to better health outcomes for this patient demographic.
Topics covered:
- The importance of incorporating the pediatric perspective in patient research
- Overcoming challenges and sensitivity considerations in pediatric market research
- Case studies showcasing successful value of pediatric insights and a shared voice in decision making
- Considerations and techniques for engaging young patients and their families
- The long-term benefits of understanding patient experiences from childhood through young adulthood
If you would like to discuss how you can elevate your insights or request more details on the topics covered in the podcast episode – Contact us.
Episode speakers
Jenny Payne, Director, Patient Strategy
Ettya Fremont (PhD), Senior Account Manager
Lucy Galoppa, Account Manager
Tanya Mubayiwa, Account Manager
Excluding pediatric patients from research ultimately results in missing a fundamental piece of that disease experience and the patient journey from their perspective… You’re only getting a retrospective view of it as an adult, which can really weaken the depth of any products’ market impact and even the commercial reach.